Daré Bioscience, Inc. (DARE)
0.4074
-0.04
(-9.86%)
USD |
NASDAQ |
Nov 20, 16:00
0.4092
0.00 (0.00%)
After-Hours: 20:00
Daré Bioscience EPS Diluted (Quarterly) : -0.1813 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1813 |
| June 30, 2026 | -0.2003 |
| March 31, 2026 | -0.2066 |
| December 31, 2025 | -0.0994 |
| September 30, 2025 | -0.2793 |
| June 30, 2025 | -0.4528 |
| March 31, 2025 | -0.4999 |
| September 30, 2024 | -0.551 |
| June 30, 2024 | 1.523 |
| March 31, 2024 | -0.8065 |
| December 31, 2023 | -0.6071 |
| September 30, 2023 | -1.094 |
| June 30, 2023 | -1.217 |
| March 31, 2023 | -1.129 |
| December 31, 2022 | -2.255 |
| September 30, 2022 | -0.9931 |
| June 30, 2022 | 0.0582 |
| March 31, 2022 | -1.201 |
| December 31, 2021 | -1.364 |
| September 30, 2021 | -2.148 |
| June 30, 2021 | -2.18 |
| March 31, 2021 | -1.975 |
| December 31, 2020 | -2.618 |
| September 30, 2020 | -2.883 |
| June 30, 2020 | -3.201 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.156 |
| December 31, 2019 | -2.498 |
| September 30, 2019 | -2.441 |
| June 30, 2019 | -3.533 |
| March 31, 2019 | -3.206 |
| December 31, 2018 | -3.064 |
| September 30, 2018 | -2.705 |
| June 30, 2018 | -3.763 |
| March 31, 2018 | -10.56 |
| December 31, 2017 | -18.12 |
| September 30, 2017 | -3.96 |
| June 30, 2017 | -66.00 |
| March 31, 2017 | -32.40 |
| December 31, 2016 | -20.40 |
| September 30, 2016 | -43.20 |
| June 30, 2016 | -48.00 |
| March 31, 2016 | -58.80 |
| December 31, 2015 | -46.80 |
| September 30, 2015 | -46.80 |
| June 30, 2015 | -44.40 |
| March 31, 2015 | -49.20 |
| December 31, 2014 | -44.40 |
| September 30, 2014 | -33.60 |
| June 30, 2014 | -52.80 |
| March 31, 2014 | -444.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | -0.7859 |
| Aytu BioPharma, Inc. | -0.2008 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.158M |
| Revenue (Quarterly) | 0.0476M |
| Total Expenses (Quarterly) | 3.206M |
| Enterprise Value | 3.283M |
| Gross Profit Margin (Quarterly) | -1.64K% |
| Profit Margin (Quarterly) | -6.63K% |
| Earnings Yield | -168.8% |
| Normalized Earnings Yield | -168.76 |